(Q26782794)

30 June 2019

3 references

17 September 2019

19 September 2019

14 October 2020

Generation of Aptamers with an Expanded Chemical Repertoire (English)

1 reference

30 June 2019

biomedical investigative technique

1 reference

17 September 2019

1 reference

19 September 2019

1 reference

14 October 2020

2

1 reference

30 June 2019

author name string

Stella Diafa

series ordinal

1

1 reference

30 June 2019

language of work or name

English

0 references

publication date

14 September 2015

4 references

30 June 2019

17 September 2019

19 September 2019

14 October 2020

4 references

30 June 2019

17 September 2019

19 September 2019

14 October 2020

20

1 reference

30 June 2019

issue

9

1 reference

30 June 2019

page(s)

16643-16671

1 reference

30 June 2019

Creative Commons Attribution

copyright license

3 references

17 September 2019

19 September 2019

14 October 2020

0 references

The chemical biology of aptamers

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Forty years of in vitro evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Catalytic DNA (deoxyribozymes) for synthetic applications-current abilities and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A Highlight of Recent Advances in Aptamer Technology and Its Application

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Current approaches in SELEX: An update to aptamer selection technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

SELEX with modified nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Instability and decay of the primary structure of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Nucleoside triphosphates--building blocks for the modification of nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Potent 2'-amino-, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Molecular evolution of functional nucleic acids with chemical modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Toward safe genetically modified organisms through the chemical diversification of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

The XNA world: progress towards replication and evolution of synthetic genetic polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Towards XNA nanotechnology: new materials from synthetic genetic polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Application of aptamers for targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Aptamers as therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A review of therapeutic aptamer conjugates with emphasis on new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Aptamers: an emerging class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

RNA aptamers as reversible antagonists of coagulation factor IXa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Aptamer photoregulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Selection of an aptamer antidote to the anticoagulant drug bivalirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Nucleic acid aptamers in cancer research, diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

In vivo Fluorescence Imaging of Tumors using Molecular Aptamers Generated by Cell‐SELEX

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Diagnostic applications of gastric carcinoma cell aptamers in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Protein-inspired modified DNAzymes: dramatic effects of shortening side-chain length of 8-imidazolyl modified deoxyadenosines in selecting RNaseA mimicking DNAzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Directed evolution of polymerase function by compartmentalized self-replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Methods for the directed evolution of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Engineered DNA Polymerases in Biotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

DNA polymerases engineered by directed evolution to incorporate non-standard nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Enzymatic recognition of 2'-modified ribonucleoside 5'-triphosphates: towards the evolution of versatile aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Modified RNA sequence pools for in vitro selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Prion-protein-specific aptamer reduces PrPSc formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A Y2 receptor mimetic aptamer directed against neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Isolation of virus-neutralizing RNAs from a large pool of random sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2′F-RNA Aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Direct in vitro selection of a 2'-O-methyl aptamer to VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

SELEX and dynamic combinatorial chemistry interplay for the selection of conjugated RNA aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Inhibition of cell proliferation by an anti-EGFR aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

In vivo activity of nuclease-resistant siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Selection of 2'F-modified RNA aptamers against prostate-specific antigen and their evaluation for diagnostic and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

In vivo selection of tumor-targeting RNA motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

In vivo SELEX for Identification of Brain-penetrating Aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Targeting Axl with an high-affinity inhibitory aptamer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

RNA based antagonist of NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Retracted: Differential SELEX in Human Glioma Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Stabilized Interleukin-6 receptor binding RNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

CD28 aptamers as powerful immune response modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Identification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Selection strategy to generate aptamer pairs that bind to distinct sites on protein targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A Y639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with non-canonical NTPs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Expanding the substrate repertoire of a DNA polymerase by directed evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Evolution of a T7 RNA polymerase variant that transcribes 2'-O-methyl RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Screening mutant libraries of T7 RNA polymerase for candidates with increased acceptance of 2'-modified nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

New NTP analogs: the synthesis of 4'-thioUTP and 4'-thioCTP and their utility for SELEX

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Investigations toward the selection of fully-modified 4'-thioRNA aptamers: optimization of in vitro transcription steps in the presence of 4'-thioNTPs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Amplification of 4'-thioDNA in the presence of 4'-thio-dTTP and 4'-thio-dCTP, and 4'-thioDNA-directed transcription in vitro and in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

PCR amplification of 4'-thioDNA using 2'-deoxy-4'-thionucleoside 5'-triphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

The synthesis of 2'-methylseleno adenosine and guanosine 5'-triphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Synthesis of DNA fragments containing 2'-deoxy-4'-selenonucleoside units using DNA polymerases: comparison of dNTPs with O, S and Se at the 4'-position in replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Thioaptamers targeting dengue virus type-2 envelope protein domain III.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

X-aptamers: a bead-based selection method for random incorporation of druglike moieties onto next-generation aptamers for enhanced binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Enzymatic synthesis of phosphoroselenoate DNA using thymidine 5'-(alpha-P-seleno)triphosphate and DNA polymerase for X-ray crystallography via MAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Formation of phosphonester bonds catalyzed by DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Boron-containing aptamers to ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A versatile toolbox for variable DNA functionalization at high density.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Synthesis of deoxynucleoside triphosphates that include proline, urea, or sulfonamide groups and their polymerase incorporation into DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Synthesis of base-modified 2'-deoxyribonucleoside triphosphates and their use in enzymatic synthesis of modified DNA for applications in bioanalysis and chemical biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Quantitative analysis of receptors for adenosine nucleotides obtained via in vitro selection from a library incorporating a cationic nucleotide analog

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A novel, modification-dependent ATP-binding aptamer selected from an RNA library incorporating a cationic functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Selecting aptamers for a glycoprotein through the incorporation of the boronic acid moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Efficacy of base-modification on target binding of small molecule DNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Modified DNA aptamer that binds the (R)-isomer of a thalidomide derivative with high enantioselectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Recent strategies targeting HIV glycans in vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Multivalent glycocluster design through directed evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Directed evolution of 2G12-targeted nonamannose glycoclusters by SELMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

High temperature SELMA: evolution of DNA-supported oligomannose clusters which are tightly recognized by HIV bnAb 2G12.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Arginine-modified DNA aptamers that show enantioselective recognition of the dicarboxylic acid moiety of glutamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Expanding the chemistry of DNA for in vitro selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Polymerase incorporation of a 2'-deoxynucleoside-5'-triphosphate bearing a 4-hydroxy-2-mercaptobenzimidazole nucleobase analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Life's simple measures: unlocking the proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Quantitative, high-resolution proteomics for data-driven systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Aptamer-based multiplexed proteomic technology for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Kinetic Proofreading: A New Mechanism for Reducing Errors in Biosynthetic Processes Requiring High Specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Mirror-design of L-oligonucleotide ligands binding to L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Mirror-image RNA that binds D-adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Reflections on a novel therapeutic candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

L-Pentoses in biological and medicinal applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A cross-chiral RNA polymerase ribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(®) therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A mixed mirror-image DNA/RNA aptamer inhibits glucagon and acutely improves glucose tolerance in models of type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Binding of a structured D-RNA molecule by an L-RNA aptamer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Chemical etiology of nucleic acid structure

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Synthetic genetic polymers capable of heredity and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Generation of high-affinity DNA aptamers using an expanded genetic alphabet

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Catalysts from synthetic genetic polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Exploring the potential impact of an expanded genetic code on protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A synthetic approach to abiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A semi-synthetic organism with an expanded genetic alphabet

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Structural basis for a six nucleotide genetic alphabet

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Evolution of functional six-nucleotide DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Nucleic acids with a six-membered 'carbohydrate' mimic in the backbone

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Kinetic analysis of an efficient DNA-dependent TNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

DNA polymerase-mediated synthesis of unbiased threose nucleic acid (TNA) polymers requires 7-deazaguanine to suppress G:G mispairing during TNA transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

An in vitro selection system for TNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Darwinian evolution of an alternative genetic system provides support for TNA as an RNA progenitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Biological activity and biotechnological aspects of locked nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Scaffolding along nucleic acid duplexes using 2'-amino-locked nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Polymerase chain reaction and transcription using locked nucleic acid nucleotide triphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Efficient reverse transcription using locked nucleic acid nucleotides towards the evolution of nuclease resistant RNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Amplification and re-generation of LNA-modified libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

2',4'-BNA/LNA aptamers: CE-SELEX using a DNA-based library of full-length 2'-O,4'-C-methylene-bridged/linked bicyclic ribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Selection of LNA-containing DNA aptamers against recombinant human CD73.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

In vitro selection of DNA-based aptamers that exhibit RNA-like conformations using a chimeric oligonucleotide library that contains two different xeno-nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Isoguanine and 5-methyl-isocytosine bases, in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Polymerase-directed synthesis of C5-ethynyl locked nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

In vitro selection with artificial expanded genetic information systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

A method for selecting modified DNAzymes without the use of modified DNA as a template in PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Polymerase engineering: towards the encoded synthesis of unnatural biopolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Kinetics of RNA Degradation by Specific Base Catalysis of Transesterification Involving the 2‘-Hydroxyl Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200916643

Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen

21 January 2018

1 reference

12 December 2020

Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity

1 reference

12 December 2020

Antidote-mediated control of an anticoagulant aptamer in vivo

1 reference

12 December 2020

Deoxynucleoside triphosphates bearing histamine, carboxylic acid, and hydroxyl residues--synthesis and biochemical characterization

1 reference

12 December 2020

Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.

1 reference

12 December 2020

Stereoisomers of deoxynucleoside 5'-triphosphates as substrates for template-dependent and -independent DNA polymerases

1 reference

12 December 2020

Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding.

1 reference

12 December 2020

10.3390/MOLECULES200916643

Identifiers

DOI

1 reference

30 June 2019

OpenCitations bibliographic resource ID

1856385

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

30 June 2019

PubMed publication ID

26389865

1 reference

30 June 2019